2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Unknown
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Conditions
Prostatic Neoplasms
9
Breast Neoplasms
7
Carcinoma, Non-Small-Cell Lung
6
Pancreatic Neoplasms
4
Neoplasms
4
Nasopharyngeal Carcinoma
3
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Neoplasm Metastasis
2
Meningioma
2
Liver Neoplasms
2
HER2-positive Breast Cancer
2
Glioma
2
Glioblastoma
2
Chordoma
2
Carcinoma, Hepatocellular
2
Carcinoma, Adenoid Cystic
2
Brain Neoplasms
2
Uterine Neoplasms
1
Triple Negative Breast Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Small Cell Lung Carcinoma
1
Sinonasal undifferentiated carcinoma
1
Resectable Lung Non-Small Cell Carcinoma
1
Radiation Injuries
1
Pituitary Neoplasms
1
Oligodendroglioma
1
Neurilemmoma
1
Nerve Sheath Neoplasms
1
Interventions
Nivolumab
6
Imatinib Mesylate
4
Ipilimumab
3
Cetuximab
3
pembrolizumab
2
palbociclib
2
Specimen Handling
2
Radiotherapy
2
Radiosurgery
2
Protons
2
Proton Therapy
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
Cyclophosphamide
2
tazemetostat
1
spartalizumab
1
relatlimab
1
nilotinib
1
camrelizumab
1
avelumab
1
atezolizumab
1
apatinib
1
Zoledronic Acid
1
X-Rays
1
Tiragolumab
1
Thiotepa
1
Surveys and Questionnaires
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Photochemotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Chordoma
×
Protons
×
Clear all
NCT01811394
2023-12-06
ISAC
Heidelberg University
Phase 2
Unknown
100 enrolled
NCT01182779
2010-08-17
HIT-1
Heidelberg University
Phase 3
Unknown
319 enrolled